About the Contextual Factors Working Group
In 2012, ‘contextual factors’ was introduced for the first time in the OMERACT process, but identifying, understanding and approaching contextual factors proved difficult. The Contextual Factors Working Group (CFWG) was formed to provide guidance on how to address these challenges. An essential part of the research plan includes developing an operational definition and guidance on how to address contextual factors in rheumatology trials, when developing core outcome measurement sets
Robin Christensen
Co-Chair
Lyn March
Co-Chair
Peter Tugwell
Co-Chair
Farwa Asim
Fellow
Midhat Kamal
Fellow
Max Mischkewitz
Fellow
Niti Goel
Patient Research Partner
Amye Leong
Patient Research Partner
OMERACT consensus-based operational definition of contextual factors:
Overview of the consensus-based operational definition of contextual factors. The three contextual factor types describe different ways that contextual factors can influence the results of a trial. Brief descriptions of each type are shown in the figure. All three types are described in detail in the material below. In short, EM-CFs modify the treatment effect (i.e. some patient subgroups experience greater or less effect from a treatment compared to other subgroups). OI-CFs are prognostic factors (sometimes called risk factors), i.e. factors predicting the course of a patient’s condition and may confound the results of trials that are not randomized. MA-CFs influence the performance of outcome measurement instruments (such as reliability, validity, responsiveness, etc.). To guide which specific factors could be considered contextual factors, the factors must fit within one of the three classification categories, i.e. either personal-, disease-related, or environmental factors. The contextual factor types are not mutually exclusive, so some specific factors, e.g. sex, may both be an EM-CF, OI-CF, and MA-CF. CFs, Contextual Factors. Figure published in Nielsen et al. Semin Arthritis Rheum. 2021 Jun;51(3):601-606.